Loading the company…
Loading the company…
In the last ten years FDA made 10 decisions for G21 (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2020 (3). The latest was on 2025-09-15.
| Family | Decisions on record |
|---|---|
| Kyphoplasty & vertebroplasty | 1 |
| G1 40 Radiopaque Bone Cement |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to G21.